The Prognostic Value of E-Cadherin, α-, β-, and γ-Catenin in Urothelial Cancer of the Upper Urinary Tract

European Urology

Volumn 49, Issue 5, 2006, Pages 839-845

  Kashibuchi, Keishi ^a   Tomita, Kyoichi ^a   Schalken, Jack A ^b   Kume, Haruki ^a   Yamaguchi, Takuhiro ^c   Muto, Satoru ^d   Horie, Sigeo ^d   Kitamura, Tadaichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF TOKYO   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bladder recurrence; Catenin; E cadherin; Prognostic factor; Upper urinary tract; Urothelial cancer

Indexed keywords

ALPHA CATENIN; BETA CATENIN; BIOLOGICAL MARKER; PARAFFIN; PLAKOGLOBIN; UVOMORULIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MULTIVARIATE ANALYSIS; NEPHROURETERECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; ALPHA CATENIN; BETA CATENIN; CADHERINS; FEMALE; FOLLOW-UP STUDIES; GAMMA CATENIN; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 33645785631     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.12.023     Document Type: Article

References (24)

1. Oosterlinck W., Solsna E., Meijden A.P.M., et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46 (2004) 147-154
2. Huben R.P., Mounzer A.M., and Murphy G.P. Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 62 (1988) 2016-2020
3. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251 (1991) 1451-1455
4. Gumbiner B.M., and McCrea P.D. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci 17 (1993) 155-158
5. Nathke I., Hinck L., and Nelson J. Epithelial cell adhesion and development of cell surface polarity possible mechanisms for modulation of cadherin function, organization and distribution. J Cell Sci 17 (1993) 139-145
6. Peifer M. Cancer, catenins and cuticle pattern: a complex connection. Science 262 (1993) 1667-1668
7. Ozawa M., Nuruki K., Toyoyama H., and Ohi Y. Cloning of an alternative form of plakoglobin (gamma-catenin) lacking the fourth armadillo repeat. J Biochem 118 (1995) 836-840
8. Bringuier P.P., Umbas R., Schaafsma E., Karthaus H.F.M., de Bruyne F.M.J., and Schalken J.A. Decreased E-cadherin immunoreactivity correlate with poor survival in patients with bladder tumors. Cancer Res 53 (1993) 3241-3245
9. Syrugos K.N., Krausz T., Waxman J., et al. E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade and tumor stage and survival. Int J Cancer 64 (1995) 367-370
10. Nakanishi K., Kawai T., Torikata C., Aurues T., and Ikeda T. E-cadherin expression in upper urinary tract carcinoma. Int J Cancer 74 (1997) 446-449
11. Inoue K., Kamada M., Slaton J.W., et al. The prognostic value of angiogenesis and metastasis related genes for progression of transitional cell carcinoma of the renal pelvis and ureter. Clin Cancer Res 8 (2002) 1863-1870
12. cas) in bladder tumors. Cancer Res 56 (1996) 4154-4158
13. Syrigos K., Harrington K., Waxman J., Krausz T., and Pignattelli M. Alterd γ-catenin expression correlates with poor survival in patient with bladder cancer. J Urol 160 (1998) 1889-1893
14. Epstein J.I., Amin M.B., Reuter V.R., Mostfi F.K., and The bladder Consensus Conference Committee. The World Health Organization/International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22 (1998) 1435-1438
15. TNM classification of Malignant Tumors: UICC 2002.
16. Umbas R., Schalken J.A., Aalders T.W., et al. Expression of the cellar adhesion molecule E-cadherin is reduced or absent in high grade prostate cancer. Cancer Res 52 (1992) 5104-5109
17. Jankowski J., Newham P., Kandemir O., Hirano S., Takeichi M., and Pignatelli M. Differential expression of E-cadherin in normal, metaplastic and dysplastic oesophageal mucosa: a putative biomarker. Int J Oncol 4 (1994) 441-448
18. Frixen U.H., Behrens J., Sachs M., et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113 (1991) 173-185
19. Vleminckx K., Vacket L., Mareel M., Fiers W., and van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66 (1991) 107-119
20. Wakatsuki S., Watanabe R., Saito K., et al. Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder. Cancer Lett 103 (1996) 11-17
21. van der Poel H.G., Antonini N., Tinteren H., and Horenblas S. Upper urinary tract cancer: location is correlated with prognosis. Eur Urol 48 (2005) 438-444
22. Shariat S.F., Pahlavan S., Baseman A.G., Brown R.M., Green A.E., Wheeler T.M., et al. E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. Urology 57 (2001) 60-65
23. Byrne R.R., Shariat S.F., Brown R., Kattan M.W., Morton Jr. R.A., Wheeler T.M., et al. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term follow up. J Urol 165 (2001) 1473-1479
24. Gontero P., Banisadr S., Frea B., and Brausi M. Metastasis marker in bladder cancer: a review of the literature and clinical considerations. Eur Urol 46 (2004) 296-311